The US warfarin sensitivity test market is expanding due to increasing adoption of personalized medicine and advanced genetic testing solutions. The growing need for safer anticoagulant therapy management, strong healthcare infrastructure, and rising use of pharmacogenomic approaches are supporting market growth. Healthcare providers are focusing on improving treatment accuracy and reducing...